Simsen® Personal ctDNA Monitoring Service
Minimal Residual Disease (MRD) & Treatment Monitoring across Solid Tumors
CommercialActive
Key Facts
Indication
Minimal Residual Disease (MRD) & Treatment Monitoring across Solid Tumors
Phase
Commercial
Status
Active
Company
About Simsen Diagnostics
Simsen Diagnostics is a Stockholm-based diagnostics company developing and commercializing a highly sensitive, tumor-informed ctDNA sequencing platform called Simsen® Personal. The company operates as a service provider, offering tailored assay design, analysis, and interpretation to support clinical trials for pharma partners and personalized monitoring for cancer clinics. By focusing on ultra-sensitive detection (down to 0.001% variant allele frequency), Simsen aims to improve early cancer detection, MRD monitoring, and drug development efficiency, positioning itself at the intersection of precision diagnostics and liquid biopsy.
View full company profile